Worth E[au] - Search Results

Year	Number of Results
1914	2
1978	1
1985	2
1988	1
1990	2
1992	1
1995	1
1996	1
1997	3
1998	1
1999	1
2000	2
2002	1
2004	1
2006	1
2010	2
2013	1
2014	1
2015	2
2016	1
2017	1
2021	2
2022	1
2023	2
2024	0

1

Ibandronate: a clinical pharmacological and pharmacokinetic update.

Barrett J, Worth E, Bauss F, Epstein S. Barrett J, et al. Among authors: worth e. J Clin Pharmacol. 2004 Sep;44(9):951-65. doi: 10.1177/0091270004267594. J Clin Pharmacol. 2004. PMID: 15317823 Review.

2

Glycosylated hemoglobin and hyperbaric oxygen coverage denials.

Moffat AD, Worth ER, Weaver LK. Moffat AD, et al. Among authors: worth er. Undersea Hyperb Med. 2015 May-Jun;42(3):197-204. Undersea Hyperb Med. 2015. PMID: 26152104 Review.

3

Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation.

Worth EH, Fugate MK, Ferrone FA. Worth EH, et al. Biophys J. 2023 Jul 11;122(13):2782-2790. doi: 10.1016/j.bpj.2023.05.034. Epub 2023 Jun 2. Biophys J. 2023. PMID: 37270670

4

A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers.

Huang ET, Mansouri J, Murad MH, Joseph WS, Strauss MB, Tettelbach W, Worth ER; UHMS CPG Oversight Committee. Huang ET, et al. Among authors: worth er. Undersea Hyperb Med. 2015 May-Jun;42(3):205-47. Undersea Hyperb Med. 2015. PMID: 26152105 Review.

5

Age-related macular degeneration and hyperbaric oxygen.

Worth ER, Carver JA. Worth ER, et al. Undersea Hyperb Med. 2010 Sep-Oct;37(5):375; author reply 376-8. Undersea Hyperb Med. 2010. PMID: 20929187 No abstract available.

6

An α-chain modification rivals the effect of fetal hemoglobin in retarding the rate of sickle cell fiber formation.

Worth EH, Fugate MK, Grasty KC, Loll PJ, Bishop MF, Ferrone FA. Worth EH, et al. Sci Rep. 2023 Dec 11;13(1):21997. doi: 10.1038/s41598-023-48919-3. Sci Rep. 2023. PMID: 38081985 Free PMC article.

7

Co-occurrence of large branchiopods and killifish in African savannah ponds.

Pinceel T, Vanden Berghen B, Buschke F, Waterkeyn A, da Costa Nerantzoulis I, Rodrigues M, Thoré E, Burrough R, Worth E, Brendonck L. Pinceel T, et al. Among authors: worth e. Ecology. 2021 Dec;102(12):e03505. doi: 10.1002/ecy.3505. Epub 2021 Sep 6. Ecology. 2021. PMID: 34319594 No abstract available.

8

Omega-3 fatty acids promote neuroprotection, decreased apoptosis and reduced glial cell activation in the retina of a mouse model of OPA1-related autosomal dominant optic atrophy.

Kalogerou M, Ioannou S, Kolovos P, Prokopiou E, Potamiti L, Kyriacou K, Panagiotidis M, Ioannou M, Fella E, Worth EP, Georgiou T. Kalogerou M, et al. Among authors: worth ep. Exp Eye Res. 2022 Feb;215:108901. doi: 10.1016/j.exer.2021.108901. Epub 2021 Dec 20. Exp Eye Res. 2022. PMID: 34933001 Free article.

9

Bayesian adaptive designs in single ascending dose trials in healthy volunteers.

Guédé D, Reigner B, Vandenhende F, Derks M, Beyer U, Jordan P, Worth E, Diack C, Frey N, Peck R. Guédé D, et al. Among authors: worth e. Br J Clin Pharmacol. 2014 Aug;78(2):393-400. doi: 10.1111/bcp.12344. Br J Clin Pharmacol. 2014. PMID: 24528176 Free PMC article.

10

The study of topical oxygen use.

Worth ER. Worth ER. Ostomy Wound Manage. 2010 Aug;56(8):10; discussion 10. Ostomy Wound Manage. 2010. PMID: 21495444 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year